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There are well documented benefits to involving patients and the public in research.
However, there is little research published about their involvement in large complex
studies such as cohort multiple Randomised Controlled Trials (cmRCTs). The cmRCT
method establishes a group of participants, with a common characteristic (e.g. older
people) who will be followed over a number of years. Other (sub) studies can also
recruit from this pool of people. This method offers researchers many advantages,
including being able to recruit from more hard to reach groups. However, cmRCTs
also have features which can make it more complicated to involve patients and the
public. For example more than one study may take place at the same time; studies
may be spread out over a large geographical area and they may include a wide range of
topics. In spite of these difficulties we have developed a way of working with patients,
the public and researchers that provides stability over time but allows flexibility along
the way. Our model of working has saved us time and money; helped us to recruit more
widely, and enabled us to focus our research in areas that are important to older people
with frailty.
Abstract
Background
There is increasing guidance on how to make the most of the rich seam of data
provided by large cohort studies, and growing recognition of the benefits of cohort
multiple Randomised Controlled Trials (cmRCT) in health research. In contrast, there is a
lack of discussion about patient and public involvement and engagement (PPIE) in
these large and complex research infrastructures. Our aim was to create a structure to
enable meaningful, sustainable public involvement within the cmRCT framework. We
have established a core reference group of four key individuals with extensive links
to other relevant local community structures and individuals.
Results
Using the CARE 75+ model we have engaged with a wide variety of patients and
the public in a relatively short space of time. Activities have included scrutiny of
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protocols and assessment tools, and process evaluations; resulting in system
efficiencies, increased recruitment and a more focused research agenda.
Conclusions
There is a need for strong public oversight and flexible models of PPIE in cmRCTs.
The model of PPIE developed in the Community Ageing Research 75+ study
presents one potential way to foster expertise and enable diversity.
Keywords: cmRCT, Public, Involvement, Engagement, Participation
Abbreviations: AHSN, Academic Health Science Network; BME, Black Minority
Ethnic; CLAHRC, Collaboration for Leadership in Applied Health Research and Care;
cmRCT, Cohort multiple Randomised Controlled Trial; FOG, Frailty Oversight Group;
MRC, Medical Research Council; PE, Public engagement; PIC, Patient Identification
Site; PPIE, Patient and public involvement and engagementBackground
This paper is based on the experience of running the Community Ageing Research 75+
(CARE 75+) study (ISRCTN16588124). This study is part of a programme of studies
investigating the Primary Care Based Management of Frailty in Older People as part of
the National Institute for Health Research Collaboration for Leadership in Applied
Health Research and Care (NIHR CLAHRC) in Yorkshire and the Humber [1].
The central tenet of this paper is that new models of PPIE will need to be developed to
ensure meaningful, sustainable, public oversight in cohort multiple randomised controlled
trials (cmRCT). The discussion will draw on our own experience of developing the CARE
75+ study and in so doing we will briefly outline:
1) the CLAHRC Frailty theme
2) development of the cmRCT methodology, and
3) the unique proposition that cmRCTs present for public engagement.
Frailty is a condition characterised by loss of biological reserve and vulnerability to ad-
verse outcomes [2]. The current health and social care response to frailty is largely reactive
to acute crises and is predominantly located in secondary care. We have established the Pri-
mary care-based management of frailty theme as part of the NIHR CLAHRC programme
[1]. The aim of this work is to enable a new approach to frailty that is proactive and pre-
ventative, predominantly located in primary and community care.
A key component of our NIHR CLAHRC programme of work has been the Community
Ageing Research CARE 75+ study. We have recruited a cohort of older people across the
frailty spectrum to investigate frailty transitions and evaluate frailty interventions using a
novel cmRCT design [3]. Following recruitment and baseline assessment, participants are
followed up at 6, 12, 24 and 48 months. A range of health, social and economic data is
collected along with demographic information, and information about social networks. In
addition, blood samples are collected for storage in a bio-bank for use in future studies.
Alongside the observational study, the cohort is being used as a recruitment platform
for qualitative and quantitative studies. It is intended that once numbers increase in the
cohort, it will provide a platform for definitive randomised controlled trials. Initially,
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trolled trials. A range of possible interventions exist – to date there has been interest
from researchers working in the areas of dermatology, diet and nutrition, community
infection, social networks and pain.Cohort multiple Randomised Control Trials (cmRCT)
The cmRCT method is based on establishing a longitudinal observational cohort from
which other (sub) studies can recruit. The original cohort is used as a ‘patient identification
site’ (PIC). CmRCTs are best suited to acute clinical conditions and chronic conditions - for
which many different types of interventions may be trialled concurrently. They are also
beneficial for conditions for which previous trials have struggled with recruitment [4].
Two key features of the cmRCT are ‘active recruitment’ and ‘embedded controls’.
Using a model of ‘real world’ or ‘patient centred’ information’ – only those actively par-
ticipating in a sub-study receive patient information. Cohort participants who are not
recruited to the intervention arm of a sub-study will have their background observa-
tional data used for control purposes (consent for this is sought at the time of original
recruitment to the cohort) [4]. In this way, cmRCTs facilitate the inclusion of cogni-
tively impaired participants, and other hard to reach groups, who, as controls, are not
required to review new study information.
Although, the inclusion of those with cognitive impairment at the outset is still pre-
scribed by the study design i.e. dependent on the advice of a consultee and not by an
adapted trial design, the potential for an individual to be included if they develop cogni-
tive impairment during the lifetime of the study is greater as they will have had an
opportunity to make the decision in advance.
In addition, multiple interventions can be trialled concurrently in one cohort.
CmRCTs can facilitate meta-analysis using standardised outcome measures across stud-
ies - assuming there is an agreed minimum dataset; maximising resources and minimis-
ing participant burden.
Historically, clinical trials of interventions for older people are characterised by low
recruitment rates for a number of reasons, such as exclusion criteria – in particular
cognitive impairment [3], patient preferences, and ethical dilemmas [4]. This has
resulted in a limited evidence base for treatments and services for older people. It is
therefore expected that using a cmRCT method will improve research in populations
of older people and the evidence based outcomes.
Despite the potential of this increasingly popular methodology there is an absence of
guidance about how PPIE activity fits with this study design. The Medical Research
Council (MRC) guidelines on maximising the value of large cohorts notes ‘stakeholder’
engagement but does not discuss the potential role of the public especially with regard
to increasing retention and recruitment [5].. Furthermore, a review of birth cohorts
suggest that public engagement (PE) should be ‘strengthened’ [6], but offers little indi-
cation of how this could be practicably achieved.The need for engagement
The arguments for public involvement in cohort studies are the same as those given
for involvement in any health service research. There are moral, political, economic
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from design to dissemination [7, 8].
The national and international importance of involving ‘consumers’ in service design
and research has long been recognised [9]. Organisations such as INVOLVE testify to
the government’s commitment to public and service user engagement in the research
process in the UK [10]. Moreover, most major UK health research funders such as
NIHR and MRC advocate public involvement in research or expect valid reasons as to
why it has not been included in applications [11, 12].
Most systematic reviews of PPIE conclude that attempts to conceptualise, evaluate
and report outcomes are still in their infancy [11, 13]. Nevertheless, there are already
many descriptive reports of the benefit of PPIE from individual studies [12, 14, 15].Additional considerations for cmRCTs
Over the past 10 years there has been a development of strong values and principles
which should underpin PPIE work [16, 17] alongside toolkits which support the practical
application of these [18, 19]. Alongside these there is agreement that PPIE cannot be pre-
scriptive and flexibility is needed to ensure the activity is meaningful, appropriate and im-
pactful within any given context. There are numerous examples of good practice from
individual studies. However, there is little in the way of guidance about which paradigms
might best support specific study types [6, 20]. Whilst briefing notes for researchers
present potential benefits and challenges to PPIE in different clinical trial scenarios they
do not suggest any specific mechanisms which would work best in these scenarios [21].
We believe there are additional considerations which should influence the structure
of PPIE in cohorts used as a platform for multiple studies.
Firstly, it is imperative that there is monitoring and scrutiny of the original aims and ob-
jectives of the observational study for which the cohort was developed. For example, when
new studies wish to utilise the cohort they may require additional outcome measures or
propose duplicating/modifying some existing measures. All changes need to be reviewed
carefully and objectively to avoid any unnecessary additional burden on the participants.
Secondly, the recruitment and retention of lay representatives needs to be considered.
In longitudinal observational cohort studies, perhaps more than in shorter studies, public
representation may be better served by community organisations than by individuals.
Thirdly, as with all cohort populations, older people with frailty are not a homogenous
group – there is huge diversity both within and across geographic regions. What is rele-
vant to an older person in Bradford may have little relevance to an older person in Bath.
This becomes increasingly important in multi-site studies where recruitment and reten-
tion rates can vary enormously [22] and be adversely affected by local context [23, 24]
But, whilst there is an acknowledgement that international trials need to consider local
context this is normally viewed through the lens of research staff and not patients or the
wider public [25]. In addition, reported reasons for differential recruitment across sites
include external publicity and conflict with other trials [26], both of which are pertinent
in cmRCTs.
Finally, the potential range of topics for sub-studies is vast. Therefore, it is unreasonable
to expect the original lay representatives to have either the time or breadth of interest to
be involved in the detail of all studies. Sub-studies require their own engagement
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order to reduce duplication and/or contradiction.The CARE 75+ cohort involvement model
Within the CLAHRC frailty theme, we were challenged to create a structure to enable
meaningful, public involvement within the cmRCT framework. We needed a structure that
had the potential to connect us to the whole spectrum of older people with frailty across a
range of cohort sub-studies in the future. What we have established is a core reference
group of four key individuals with extensive links to other relevant local community struc-
tures. Within the Frailty Oversight Group (FOG) we have lay representation from the Brad-
ford Older People’s Partnership [27], the Bradford Self-Care and Prevention Forum and a
general practice Patient Participation Group along with a BME advocate from the local au-
thority [28]. This core group undertakes a monitoring and scrutiny role for the original ob-
servational study alongside providing oversight for the wider programme of work utilising
the cohort within the frailty theme. And, provide signposting to researchers and advocacy
for participants.
At the centre we have recruited from key health and ageing organisations (Fig. 1). We
want to keep organisations on board for the duration of the cohort, mindful of the fact
that individual representatives may come and go. The representatives from these key or-
ganisations have specific expertise of their own. And, are able to network the research
team quickly and effectively to other relevant local organisations, groups or individuals
depending on the specific needs of the study. In doing so, they are able to extend the PPIE
activity for the whole of the Frailty Theme way beyond the scheduled meeting times. They
can do this because they have extensive local knowledge and long-standing relationships
engendering trust within their communities.
Core organisational members provide stability over time which means the structure is
not reliant on individuals. At a secondary level core group members will have links to spe-
cialist condition/disease groups provides patient expertise and experience. Finally, at the
widest community level, local ad hoc groups and individuals, engaged via the networks
provided by the core group members, maintain diversity and can be engaged for one-offLevel 3
FOG
Core group
Level 1
Level 2
Core group of organisational 
representatives e.g. Self Care 
and Prevention Board
Level 1: local issue/condition 
specific networks e.g.. 
osteoporosis, mental health
Level 2: local ad hoc groups 
e.g. walking groups, patient 
forums, wellbeing cafes
Level 3: Individuals
Fig. 1 CARE75+ Model of Involvement
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be used for consultation, collaboration or co-production interchangeably, as appropriate.
It is important that flexibility is retained and any members of the core group who are
interested in sub-studies can be more or less involved as they wish. In encouraging sub-
studies to regularly report back to the core group, those members can consider how sub-
study decisions might impact the wider programme of work, for example in the methods
and timing of recruitment. Sub-study groups may also provide a natural recruitment re-
source for the core group in future, and those leaving the core group can remain within
the structure at a more informal level i.e. level 3 as and when they are interested and able.
Whilst it is important that sub-studies undertake their own, bespoke, PPIE activity,
clear branding of the sub-studies will maintain an association with the original cohort.
This will improve external publicity – benefiting from PPIE work that has already taken
place, and reduce conflict with other trials by fostering a culture of collective responsi-
bility across the studies. In maintaining the brand all PPIE activity will have reach be-
yond its original aim.
Another representation of the FOG structure would be a ‘web’ of interconnectedness
(Fig. 2). But, it is not sufficient to have only one ‘web’. Our aim is to replicate the struc-
ture in different localities across the study sites to enable us to access local knowledge
and needs. Furthermore, we aim to connect each site so that learning can be shared in
adequate time across the cohort. This along with central co-ordination will allow wider
learning for sub-studies, reduce the burden on the central team and maintain equality
across the regions.
The model we have adopted embodies the values and principles of good PPIE in
the following ways: The core FOG members meet independent of the Frailty
Theme Operational Board. This is to ensure that the focus of the meetings remains
with the lay members. The project manager chairs the meetings. This role has
been offered to members who so far have declined, but the intention is to offer
the role in the future. The PI for the CARE75+ study is always required to attend
and all other researchers attend as and when necessary. Researchers advocating all
new proposals for use of the cohort are required to attend. Outcomes from the
FOG are fed into other arenas such as the overall Frailty Theme Operational
Group and study co-ordination meetings.Secondary site
Primary site
Core
Level1
Level 2
Level 3
Fig. 2 Networked Involvement ‘webs’
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the interim, and all discussions are fully documented for reference. Any issues impact-
ing beyond the scope of the group are forwarded to the relevant organisations or
groups such as the Integrated Care Board. All actions taken as a result of the FOG are
documented in the meeting minutes and followed up. Reasons for in-action are noted.
The FOG members have clear terms of reference for the scope of their work. They are
also linked to complimentary structures such as the AHSN, Improvement Academy.
Core members are financially reimbursed at a rate of £10 per hour for any time spent
engaged in project work e.g. meetings, training, observations and background reading.
This is in addition to out of pocket expenses to pay for parking or transport. Lay
members have received training in observational methods and briefings in event
facilitation and presentations before carrying out the tasks. One of the first requests
from lay members was a research language ‘jargon buster’.
Researchers from all sub-studies are required to regularly update the core members
of the FOG and make representations if necessary. The fluidity of the FOG model is
such that it can accommodate the views of individuals or groups allowing for more
diverse representation in the main cohort study and sub-studies.
Results
Work undertaken by the Frailty Oversight Group
We have been developing the FOG model for the past 18 months and already there are
a number of significant outcomes which evidence the added value of this approach
across the whole of the research cycle. In total, over 100 individuals have helped to
shape our work.
Identifying and prioritising areas of research
During the first study wide ‘Celebration Event’ of the CARE75+ study, 70 participants
were asked to prioritise a number of areas of interest to researchers including; pain,
loneliness, infection and skin health. The core FOG members were briefed to facilitate
this exercise and helped to identify loneliness and pain as important topics to take
forward within the cohort. In the following months two grant applications were
developed and submitted on those topics.
Skin health was not identified as a priority for the wider cohort participants and
within the quarterly meeting the core FOG members were able to drill down to why
exactly this was the case, providing the researcher with valuable insight with which to
refocus their proposal.
The FOG had quite an impact on my thinking – particularly their obvious lack of
enthusiasm for my work (in the nicest possible way). It’s made me think even more
about how I can convince funders that this work is worthwhile – and the need for it
to have tangible impact/patient benefit. It’s obvious really – but very powerful when
it comes directly from ‘real’ people (Researcher).
Study design
Before fieldwork started within the main cohort, core FOG members were able to
source three ‘naive’ dummy participants with whom the researchers could test out the
Heaven et al. Research Involvement and Engagement  (2016) 2:30 Page 8 of 12data collection process from start to finish. This enabled the team to go beyond ‘role
play’ in their training and help them understand the process from a participant’s point of
view. From this experience the researchers were able to demonstrate ‘content/community
validity’ [14], were confident in their approach and, able to be realistic and sensitive in
scheduling time with participants i.e. allowing more time for questions which could elicit
an emotional response. Excerpts from the test feedback illustrate the value of this exercise.
“I kept talking I did elaborate. I think they’re going to meet this anyway. A lot of
people need to talk. They were very good. They had very good listening skills. Offered
to stop to have a cup of tea” (test participant 1).
“It was very clear. They were extremely polite. They were concerned about my welfare
and that everything was alright with me. The opportunity to come back is a good
option.” (test participant 2).
Core members also sourced other individuals with experience of chronic pain to test
the proposed data collection tool for the pain study. This was a well-established tool
which has been used for a pan-European study of pain. However, within our test-bed of
frail older people we found that some of the pain descriptors were not well understood
and needed adjustment.
One of the sub-studies used the core members to signpost researchers to groups pri-
marily concerned with supporting older people in the community e.g. British Legion. In
this way they were able to develop their own specialist engagement group for the shorter
duration of the sub-study.
Development of grant proposals
Because of the close links the FOG has with related areas of work within the research
unit, one member was seconded to be a co-applicant on a Health Technology Assess-
ment bid addressing extended rehabilitation. As exercise and mobility was one of the
top three priorities identified at the Celebration Event this as considered an important
programme with which to link.
Management
Very early on the lay members identified that researchers should be mindful of not in-
creasing social isolation when withdrawing from assessments. Because of their exten-
sive local networks they were able to suggest organisations that would ensure
continuity for the participants and give them an opportunity to start building networks
if they wished. These were then added to the existing signposting resource that is made
available to the participants.
One of the on-going agenda items for the FOG is how to keep in touch with partici-
pants between assessments, which are at 6 and then 12 month intervals. The import-
ance of this contact was highlighted during the observations. To date the group have
held one ‘Celebration Event’ and are in the process of planning a second. They have
also reviewed and contributed quarterly newsletters.
Another area of interest which the FOG would like to be considered is the issue of ‘drop
out’. Core members feel it is important to understand why participants would not wish to
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in the future. However, our data suggests that the study has experienced relatively low
attrition rates (6.84 %) compared to community based trials including older people [29].
Local networks and other district wide work with older people enabled FOG mem-
bers to signpost the research team to a research active GP which resulted in increased
Black, Minority Ethnic (BME) participation to 14 %, in line with the local population.
In assuring good governance of the study the FOG members also raised the question
of how much support the researchers need/receive when they are faced with partici-
pants who may have mental health problems such as depression or dementia or seem-
ingly be very frail and vulnerable. This made the research team consider if the support
structures in place for staff were adequate.
Undertaking research
Core FOG members have been instrumental in the on-going process evaluation
through structured observations of the consent and assessment process. These observa-
tions have ensured that the participants’ best interests remain paramount but have also
highlighted considerations for the analysis and interpretation of data. For example, the
self-report of smoking habits in one case were at odds with the lay members’ observa-
tion of the environment. Other points to consider going forward included keeping in
touch between assessments, the brief time participants spend reading postal informa-
tion and appreciating the level of participant nerves at the first encounter.Analysis and interpretation
There have been many discussions about the interpretation of language and concepts
at the FOG quarterly meetings. For example, it was noted that the word ‘chrono-
logical’ was probably not widely understood and this was removed from a lay sum-
mary. In addition, the phrase ‘off legs’ to describe reduced mobility was also not well
understood by lay members and was abandoned. However, whilst these individual
discussions are useful the real value of the FOG structure lies in sharing them across
all of the sub- studies.
Having a multi-layered approach to PPIE has meant that all of the sub- studies have
benefitted from shared insight at an early stage. For example, it quickly became appar-
ent from one sub-study that it was not appropriate or meaningful to use the term
‘carer’ for those people providing informal support in the community. This was taken
on board by a subsequent study which identified those who provided support as
‘friends, family or neighbours’.
Where issues have been raised in sub-studies researchers have reported these to
the core FOG members and they in turn have been able to add another perspec-
tive or ratify the original discussion. For example, core members agreed with the
sub-study assertion that religious groups should be considered important commu-
nity support groups. But, the core group did not agree that the sub-study looking
at resourcefulness in older people should only focus on non-home owners as a
lower income group as there were expenses that could be incurred as a home
owner that would put older individuals in a similar financial position to those on
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Dissemination
In addition to their contribution to routine dissemination activities such as the quarterly
newsletters and review of the CLAHRC website, FOG members have also co-presented a
workshop at one national conference.
However, one of their central roles is in raising awareness of the CARE75+ within the
local area through their personal networks. Following an introduction to the Bradford
Older People’s forum, researchers from the CARE75+ were able to address a wider
audience and elicit views on the shape and scope of the research. This discussion
highlighted a potential area of diversity which had been overlooked i.e. inclusion of the
long-established Ukranian community in Bradford. In addition, researchers have been
invited to present the research at the Bradford Self-Care and Prevention Programme.
Discussion
Building a model of involvement across time, geographical space and communities of
interest has a number of challenges, not least the human resource required to set-up
and co-ordinate effective networks at each site. This challenge is not unique to cmRCTs
but to any complex studies or large programmes of multi-layered research such as
those funded by the CLAHRC or in international trials.
Whilst involvement may have found a place on the agenda in theory, there is still
evidence to suggest that researchers will take the path of least resistance and fail to
engage patients and the public in a meaningful way, preferring to use what is already in
existence in a tokenistic manner [7, 13, 20, 30] rather than build something bespoke.
And, although there has been an increase in the amount of resources available to guide
researchers in terms of toolkits, values and principles some still struggle to effectively
utilise these due to lack of time, resource or confidence in their approach.
We have not found any reference to PPIE models for specific study designs but
believe that in the case of cmRCTs and other complex designs a general paradigm is
useful in meeting the longitudinal objectives and making the best use of time and
resources.
At a time when there is call for the impact of PPIE to be contextualised to provide
a more strategic approach [31], practices are not well described in the context of
cohort studies. The most extensive review of engagement in cohort studies, which
included only birth cohorts describes most engagement activity at the level of infor-
mation dissemination [6]. Other cohorts offering a facility for ‘trials within cohorts’,
such as the South Yorkshire Health Study have only the briefest reference to public
engagement on their website [32] and it was confirmed by personal correspondence
that this is not an area currently being developed. Other well established ageing
cohorts also have no obvious reference to public involvement in their publications or
on their websites [33, 34].
Using the FOG model we have been able to involve a significant number of individ-
uals from our target population, i.e. older people aged over 75, across a large spectrum
of research activity, in a relatively short space of time. We have both enabled diversity
through reaching out via networks into ‘research naive’ communities and encouraged
lasting expertise, by skilling up a small core group of collaborators. Because of the
Table 1 Recommendations for PPIE in CmRCTs
Recommendations
Choose core group members from established voluntary and community groups which can provide continuity
over time
Ensure all sub-studies protocols are presented to the core group in the initial stages
Brand sub-studies to ensure they are identified as originating from the cohort
Use the core group to signpost sub-studies to further engagement opportunities with groups and individuals
Ensure sub-studies to feedback and share learning quickly
Establish links with other sites with similar remits
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cross-referencing ideas between the core group, sub-groups and individuals. We have
also been able to effectively share the outcomes amongst all researchers working within
the Frailty Theme.
Future challenges for the CARE 75+ study oversight are: to establish a network in
each of the study sites; to encourage researchers to go beyond the core oversight group,
to explore more diverse engagement opportunities and to co-ordinate the work of the
local networks to share learning effectively.
Conclusion
PPIE in cohort studies is imperative and has some unique requirements that are relevant
to other complex, multi-layered study designs. The CARE 75+ study proposes one model
of PPIE in cmRCTs which provides a structured approach to PPIE in complex and multi-
layered study designs, whilst incorporating the values and principles of good practice and
maintaining flexibility. Recommendations from the model are shown in Table 1.Acknowledgements
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